ABBV — AbbVie Inc. — Stock Newsroom

S TOCK newsroom .COM

S&P 500 6,841 +0.86%

DJIA 48,348 +0.92%

Nasdaq 25,099 +0.82%

DAX 23,937 -0.11%

Gold $4,196 +0.16%

Oil $95.76 -0.96%

BTC $72,438 +1.50%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

S&P 500 6,841 +0.86%

DJIA 48,348 +0.92%

Nasdaq 25,099 +0.82%

DAX 23,937 -0.11%

Gold $4,196 +0.16%

Oil $95.76 -0.96%

BTC $72,438 +1.50%

VIX 20.48 -15.65%

EUR/USD 1.1785 -0.02%

ETH $2,222 +0.59%

ABBV

AbbVie Inc.

NYSE

Healthcare Drug Manufacturers

$207.18

+1.98 (+0.96%)

Data provided by Interactive Brokers. Prices may be delayed.

About AbbVie Inc.

CEO: Robert Michael

Website: abbvie.com

Price Chart

Articles (1)

Mar 27, 2026 Pharma & Healthcare AbbVie Dermatology Data Boom at AAD 2026 Shocks Investors

All Articles about AbbVie Inc.

Pharma & Healthcare

AbbVie Dermatology Data Boom at AAD 2026 Shocks Investors

Can AbbVie’s latest dermatology data at AAD 2026 really secure its post-Humira growth story in immunology? Maik Kemper Editor in Chief Our robust evidence across…

Mar 27, 2026

News Feed

Real-time news feed for ABBV is coming soon.
Check back for live market news and analyst updates.